Zimmer Biomet Holdings Debt to Equity Ratio 2006-2018 | ZBH

Current and historical debt to equity ratio values for Zimmer Biomet Holdings (ZBH) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Zimmer Biomet Holdings debt/equity for the three months ending September 30, 2018 was 0.70.
Zimmer Biomet Holdings Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-09-30 $8.60B $12.22B 0.70
2018-06-30 $9.41B $12.04B 0.78
2018-03-31 $9.49B $12.00B 0.79
2017-12-31 $8.92B $11.74B 0.76
2017-09-30 $9.20B $10.45B 0.88
2017-06-30 $9.35B $10.28B 0.91
2017-03-31 $10.54B $9.93B 1.06
2016-12-31 $10.67B $9.67B 1.10
2016-09-30 $11.01B $9.75B 1.13
2016-06-30 $10.53B $9.55B 1.10
2016-03-31 $11.12B $9.66B 1.15
2015-12-31 $11.50B $9.89B 1.16
2015-09-30 $11.69B $9.99B 1.17
2015-06-30 $11.75B $10.13B 1.16
2015-03-31 $9.06B $6.58B 1.38
2014-12-31 $1.43B $6.55B 0.22
2014-09-30 $1.43B $6.54B 0.22
2014-06-30 $1.69B $6.45B 0.26
2014-03-31 $1.68B $6.24B 0.27
2013-12-31 $1.67B $6.30B 0.27
2013-09-30 $1.69B $6.14B 0.28
2013-06-30 $1.69B $5.89B 0.29
2013-03-31 $1.70B $5.71B 0.30
2012-12-31 $1.72B $5.87B 0.29
2012-09-30 $1.73B $5.83B 0.30
2012-06-30 $1.73B $5.71B 0.30
2012-03-31 $1.57B $5.66B 0.28
2011-12-31 $1.58B $5.52B 0.29
2011-09-30 $1.54B $5.61B 0.28
2011-06-30 $1.15B $6.02B 0.19
2011-03-31 $1.14B $5.86B 0.19
2010-12-31 $1.14B $5.77B 0.20
2010-09-30 $1.14B $5.82B 0.20
2010-06-30 $1.13B $5.74B 0.20
2010-03-31 $1.13B $5.71B 0.20
2009-12-31 $1.13B $5.64B 0.20
2009-09-30 $0.60B $5.98B 0.10
2009-06-30 $0.65B $5.81B 0.11
2009-03-31 $0.66B $5.56B 0.12
2008-12-31 $0.46B $5.65B 0.08
2008-09-30 $0.33B $5.62B 0.06
2008-06-30 $0.33B $5.51B 0.06
2008-03-31 $0.12B $5.71B 0.02
2007-12-31 $0.10B $5.45B 0.02
2007-09-30 $0.10B $5.25B 0.02
2007-06-30 $0.10B $5.28B 0.02
2007-03-31 $0.10B $5.12B 0.02
2006-12-31 $0.10B $4.92B 0.02
2006-09-30 $0.10B $4.80B 0.02
2006-06-30 $0.08B $4.90B 0.02
2006-03-31 $0.08B $4.92B 0.02
2005-12-31 $0.08B $4.68B 0.02
2005-09-30 $0.09B $4.51B 0.02
2005-06-30 $0.27B $4.31B 0.06
2005-03-31 $0.43B $4.15B 0.10
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $23.875B $7.824B
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $126.543B 19.40
Abbott Laboratories (ABT) United States $126.526B 25.64
Stryker (SYK) United States $64.420B 24.28
Boston Scientific (BSX) United States $51.491B 26.02
Baxter (BAX) United States $35.393B 22.86
Smith & Nephew SNATS (SNN) United Kingdom $16.038B 0.00
ResMed (RMD) United States $14.846B 28.31
Perrigo (PRGO) Ireland $8.596B 13.05
Bio-Rad Laboratories (BIO) United States $8.274B 52.91
Canopy Growth (CGC) Canada $8.174B 0.00
Hill-Rom Holdings (HRC) United States $6.270B 19.88
Aurora Cannabis (ACB) Canada $6.172B 33.68
Haemonetics (HAE) United States $5.727B 50.36
ICU Medical (ICUI) United States $4.968B 27.68
Insulet (PODD) United States $4.838B 0.00
Agios Pharmaceuticals (AGIO) United States $4.052B 0.00
Hutchison China MediTech (HCM) China $4.010B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.990B 0.00
Neogen (NEOG) United States $3.294B 49.88
NuVasive (NUVA) United States $3.166B 29.46
National Vision Holdings (EYE) United States $3.024B 58.49
Quidel (QDEL) United States $2.507B 32.68
Aphria (APHA) $2.433B 0.00
NxStage Medical (NXTM) United States $1.933B 0.00
Phibro Animal Health (PAHC) United States $1.409B 19.95
AtriCure (ATRC) United States $1.241B 0.00
Cardiovascular Systems (CSII) United States $1.058B 1524.50
VAREX IMAGING (VREX) United States $0.999B 20.07
Meridian Bioscience (VIVO) United States $0.823B 26.23
Surmodics (SRDX) United States $0.794B 121.41
OraSure Technologies (OSUR) United States $0.772B 43.48
Eagle Pharmaceuticals (EGRX) United States $0.755B 24.24
MacroGenics (MGNX) United States $0.740B 0.00
Cerus (CERS) United States $0.716B 0.00
PetIQ (PETQ) United States $0.705B 20.03
Lantheus Holdings (LNTH) United States $0.625B 19.35
Omeros (OMER) United States $0.619B 0.00
LeMaitre Vascular (LMAT) United States $0.540B 26.52
Owens & Minor (OMI) United States $0.535B 6.05
Insys Therapeutics (INSY) United States $0.527B 0.00
NanoString Technologies (NSTG) United States $0.521B 0.00
TG Therapeutics (TGTX) United States $0.444B 0.00
Evolus (EOLS) United States $0.403B 0.00
Quanterix (QTRX) United States $0.376B 0.00
Utah Medical Products (UTMD) United States $0.332B 21.45
Cytosorbents (CTSO) United States $0.313B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.264B 0.00
Surface Oncology (SURF) United States $0.225B 0.00
Rockwell Medical (RMTI) United States $0.214B 0.00
BioLife Solutions (BLFS) United States $0.204B 275.00
Bovie Medical (BVX) United States $0.198B 0.00
Chimerix (CMRX) United States $0.172B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.146B 0.00
Fonar (FONR) United States $0.141B 7.06
Imprimis Pharmaceuticals (IMMY) United States $0.123B 0.00
Chembio Diagnostics (CEMI) United States $0.106B 0.00
United-Guardian (UG) United States $0.080B 16.85
Female Health (VERU) United States $0.075B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.066B 21.07
InfuSystems Holdings (INFU) United States $0.064B 0.00
CAS Medical Systems (CASM) United States $0.053B 0.00
Neurotrope (NTRP) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Capricor Therapeutics (CAPR) United States $0.028B 0.00
Myomo (MYO) United States $0.024B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.018B 0.00
Senestech (SNES) United States $0.017B 0.00
Akers Biosciences Inc (AKER) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00